Pro-Dex (co) EBIT

As of the most recent data (June 2026), PDEX shows a EBIT of $5.3M. That compares with $12M in the prior-year period — down 57.3% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PDEX's EBIT is now $5.3M (was $12M) — a 57.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pro-Dex (co) is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Pro-Dex (co) is at $5.3M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how PDEX stacks up against individual peers as well.

Tracking PDEX's ebit over time shows whether Pro-Dex (co) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $12M in the prior-year period — down 57.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Pro-Dex (co)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $5.3M) with ownership activity and broader fundamentals.